North America Drugs for Vulvovaginal Candidiasis Market by Manufacturers, Countries, Type and Application, Forecast to 2023

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.

Scope of the Report:
This report focuses on the Drugs for Vulvovaginal Candidiasis in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group

Market Segment by Countries, covering
Miconazole
Clotrimazole
Fluconazole
Econazole
Other

Market Segment by Type, covers
Hospital & Clinic
Pharmacy

Market Segment by Applications, can be divided into
Hospital & Clinic
Pharmacy

There are 15 Chapters to deeply display the North America Drugs for Vulvovaginal Candidiasis market.

Chapter 1, to describe Drugs for Vulvovaginal Candidiasis Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Vulvovaginal Candidiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Drugs for Vulvovaginal Candidiasis, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Drugs for Vulvovaginal Candidiasis market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Drugs for Vulvovaginal Candidiasis Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents
1 Market Overview
1.1 Drugs for Vulvovaginal Candidiasis Introduction
1.2 Market Analysis by Type
1.2.1 Miconazole
1.2.2 Clotrimazole
1.2.3 Fluconazole
1.2.4 Econazole
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Hospital & Clinic
1.3.2 Pharmacy
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Mexico Status and Prospect (2013-2023)
1.4.3 Canada Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Perrigo
2.2.1 Business Overview
2.2.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Perrigo Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 J & J
2.3.1 Business Overview
2.3.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 J & J Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Pfizer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Effik
2.6.1 Business Overview
2.6.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Effik Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva
2.7.1 Business Overview
2.7.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Teva Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Sanofi Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cisen Pharmaceutical
2.9.1 Business Overview
2.9.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Kingyork Group
2.10.1 Business Overview
2.10.2 Drugs for Vulvovaginal Candidiasis Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America Drugs for Vulvovaginal Candidiasis Market Competition, by Manufacturer
3.1 North America Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
3.1.1 North America Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
3.1.2 North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer (2016-2017)
3.2 North America Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
3.2.2 North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer (2016-2017)
3.3 North America Drugs for Vulvovaginal Candidiasis Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America Drugs for Vulvovaginal Candidiasis Market Analysis by Countries
4.1 North America Drugs for Vulvovaginal Candidiasis Sales and Market Share by Countries (2013-2018)
4.1.1 North America Drugs for Vulvovaginal Candidiasis Sales by Countries (2013-2018)
4.1.2 North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
4.2 North America Drugs for Vulvovaginal Candidiasis Revenue (Value) and Market Share by Countries (2013-2018)
4.2.1 North America Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
4.2.2 North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries (2013-2018)
5 North America Market Segmentation Drugs for Vulvovaginal Candidiasis by Type
5.1 North America Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
5.1.2 North America Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2013-2018)
5.2 Type 1 Sales Growth Rate and Price
5.2 Miconazole Sales Growth and Price
5.2.1 North America Miconazole Sales Growth (2013-2018)
5.2.2 North America Miconazole Price (2013-2018)
5.3 Clotrimazole Sales Growth and Price
5.3.1 North America Clotrimazole Sales Growth (2013-2018)
5.3.2 North America Clotrimazole Price (2013-2018)
5.4 Fluconazole Sales Growth and Price
5.4.1 North America Fluconazole Sales Growth (2013-2018)
5.5 Econazole Sales Growth and Price
5.5.1 North America Econazole Sales Growth (2013-2018)
5.5.2 North America Econazole Price (2013-2018)
5.6 Other Sales Growth and Price
5.6.1 North America Other Sales Growth (2013-2018)
5.6.2 North America Other Price (2013-2018)
6 North America Market Segmentation Drugs for Vulvovaginal Candidiasis by Application
6.1 North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
6.2 Hospital & Clinic Sales Growth (2013-2018)
6.3 Pharmacy Sales Growth (2013-2018)
7 United States Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type
7.2.1 United States Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
7.2.2 United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
7.3 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2013-2018)
7.3.1 United States Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
7.3.2 United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
7.4 United States Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
8 Canada Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
8.2 Canada Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
8.2.1 Canada Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
8.2.2 Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
8.3 Canada Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2013-2018)
8.3.1 Canada Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
8.3.2 Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
8.4 Canada Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 Canada Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
8.4.2 Canada Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
8.5 Canada Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
9 Mexico Drugs for Vulvovaginal Candidiasis Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Drugs for Vulvovaginal Candidiasis Revenue, Sales and Growth Rate (2013-2018)
9.2 Mexico Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
9.2.1 Mexico Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
9.2.2 Mexico Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
9.3 Mexico Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2013-2018)
9.3.1 Mexico Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
9.3.2 Mexico Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
9.4 Mexico Drugs for Vulvovaginal Candidiasis Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Mexico Drugs for Vulvovaginal Candidiasis Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Mexico Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Manufacturer (2016-2017)
9.5 Mexico Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
10 Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2023)
10.1 North America Drugs for Vulvovaginal Candidiasis Sales, Revenue and Growth Rate (2018-2023)
10.2 Drugs for Vulvovaginal Candidiasis Market Forecast by Countries (2018-2023)
10.2.1 North America Drugs for Vulvovaginal Candidiasis Sales Forecast by Countries (2018-2023)
10.2.2 United States Drugs for Vulvovaginal Candidiasis Forecast (2018-2023)
10.2.3 Canada Drugs for Vulvovaginal Candidiasis Forecast (2018-2023)
10.2.4 Mexico Drugs for Vulvovaginal Candidiasis Forecast (2018-2023)
10.3 Drugs for Vulvovaginal Candidiasis Market Forecast by Type (2018-2023)
10.3.1 North America Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2018-2023)
10.3.2 North America Drugs for Vulvovaginal Candidiasis Market Share Forecast by Type (2018-2023)
10.4 Drugs for Vulvovaginal Candidiasis Market Forecast by Application (2018-2023)
10.4.1 North America Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2018-2023)
10.4.2 North America Drugs for Vulvovaginal Candidiasis Market Share Forecast by Application (2018-2023)
11 Drugs for Vulvovaginal Candidiasis Manufacturing Cost Analysis
11.1 Drugs for Vulvovaginal Candidiasis Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures
Figure Drugs for Vulvovaginal Candidiasis Picture
Table Product Specifications of Drugs for Vulvovaginal Candidiasis
Figure North America Sales Market Share of Drugs for Vulvovaginal Candidiasis by Types in 2017
Table Types of Drugs for Vulvovaginal Candidiasis
Figure Miconazole Picture
Figure Clotrimazole Picture
Figure Fluconazole Picture
Figure Econazole Picture
Figure Other Picture
Figure North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Applications in 2017
Table Applications of Drugs for Vulvovaginal Candidiasis
Figure Hospital & Clinic Picture
Figure Pharmacy Picture
Figure United States Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Mexico Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Vulvovaginal Candidiasis Type and Applications
Table Bayer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Drugs for Vulvovaginal Candidiasis Type and Applications
Table Perrigo Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table J & J Basic Information, Manufacturing Base and Competitors
Table J & J Drugs for Vulvovaginal Candidiasis Type and Applications
Table J & J Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Drugs for Vulvovaginal Candidiasis Type and Applications
Table Pfizer Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Type and Applications
Table Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Effik Basic Information, Manufacturing Base and Competitors
Table Effik Drugs for Vulvovaginal Candidiasis Type and Applications
Table Effik Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Drugs for Vulvovaginal Candidiasis Type and Applications
Table Teva Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Drugs for Vulvovaginal Candidiasis Type and Applications
Table Sanofi Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Type and Applications
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kingyork Group Basic Information, Manufacturing Base and Competitors
Table Kingyork Group Drugs for Vulvovaginal Candidiasis Type and Applications
Table Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Table North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer (2016-2017)
Figure North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table North America Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Table North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer (2016-2017)
Figure North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table North America Drugs for Vulvovaginal Candidiasis Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2016
Figure Top 3 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2017
Figure Top 5 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2016
Figure Top 5 Drugs for Vulvovaginal Candidiasis Manufacturer Market Share in 2017
Table North America Drugs for Vulvovaginal Candidiasis Sales by Countries (2013-2018)
Figure North America Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries (2013-2018)
Figure North America 2013 Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries
Figure North America 2017 Drugs for Vulvovaginal Candidiasis Sales Market Share by Countries
Table North America Drugs for Vulvovaginal Candidiasis Revenue by Countries (2013-2018)
Figure North America Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries (2013-2018)
Figure North America 2013 Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries
Figure North America 2017 Drugs for Vulvovaginal Candidiasis Revenue Market Share by Countries
Table North America Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Sales Share by Type (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Revenue by Type (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Revenue Share by Type (2013-2018)
Figure North America Miconazole Sales Growth (2013-2018)
Figure North America Miconazole Price (2013-2018)
Figure North America Clotrimazole Sales Growth (2013-2018)
Figure North America Clotrimazole Price (2013-2018)
Figure North America Fluconazole Sales Growth (2013-2018)
Figure North America Fluconazole Price (2013-2018)
Figure North America Econazole Sales Growth (2013-2018)
Figure North America Econazole Price (2013-2018)
Figure North America Other Sales Growth (2013-2018)
Figure North America Other Price (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table North America Drugs for Vulvovaginal Candidiasis Sales Share by Application (2013-2018)
Figure North America Hospital & Clinic Sales Growth (2013-2018)
Figure North America Pharmacy Sales Growth (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table United States Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure United States Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table United States Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure Canada Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table Canada Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure Canada Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table Canada Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure Canada Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table Canada Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure Mexico Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
Figure Mexico Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
Table Mexico Drugs for Vulvovaginal Candidiasis Sales by Type (2013-2018)
Table Mexico Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2013-2018)
Table Mexico Drugs for Vulvovaginal Candidiasis Sales by Application (2013-2018)
Table Mexico Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Table Mexico Drugs for Vulvovaginal Candidiasis Sales by Manufacturer (2016-2017)
Figure Mexico Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2016
Figure Mexico Drugs for Vulvovaginal Candidiasis Sales Market Share by Manufacturer in 2017
Table Mexico Drugs for Vulvovaginal Candidiasis Revenue by Manufacturer (2016-2017)
Figure Mexico Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2016
Figure Mexico Drugs for Vulvovaginal Candidiasis Revenue Market Share by Manufacturer in 2017
Table Mexico Drugs for Vulvovaginal Candidiasis Export and Import (2013-2018)
Figure North America Drugs for Vulvovaginal Candidiasis Sales, Revenue and Growth Rate (2018-2023)
Table North America Drugs for Vulvovaginal Candidiasis Sales Forecast by Countries (2018-2023)
Table North America Drugs for Vulvovaginal Candidiasis Market Share Forecast by Countries (2018-2023)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Forecast (2018-2023)
Figure Canada Drugs for Vulvovaginal Candidiasis Sales Forecast (2018-2023)
Figure Mexico Drugs for Vulvovaginal Candidiasis Sales Forecast (2018-2023)
Table North America Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2018-2023)
Table North America Drugs for Vulvovaginal Candidiasis Market Share Forecast by Type (2018-2023)
Table North America Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2018-2023)
Table North America Drugs for Vulvovaginal Candidiasis Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vulvovaginal Candidiasis
Figure Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
Figure Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
Table Major Buyers of Drugs for Vulvovaginal Candidiasis
Table Distributors/Traders/ Dealers List

Global Array Type Infrared Camera Market Research Report 2018

Published Date : Dec 2018

Array Type Infrared Camera Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United Sta...

Global Wankel Engines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

The Wankel engine is a type of internal combustion engine using an eccentric rotary design to convert pressure into rotating motion. In contrast to the more common reciprocating piston designs, the Wankel engine delivers advantages of simplicity, smoothness, compactness, high revolutions per minute,...

Global UV Sensors Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

UV sensors, which convert light (photons) into electric current, are elements highly sensitive to the wavelength of light in the ultra-violet region. Ultra-violet light is classified as "UV-A", "UV-B" and "UV-C", depending on the wavelength and as the wavelengths become shorter more damage is caused...

Global Silicon Nitride Ceramic Substrate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Silicon nitride ceramic substrate is a physical material that made of silicon nitride, upon which a semiconductor device, a photovoltaic cell or an integrated circuit, is applied. Silicon nitride with high thermal conductivity has emerged as one of the most promising substrate materials for the next...

Global Polycarboxylate Superplasticizer Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Polycarboxylate superplasticizer is the third generation concrete superplasticizer, which owns unique characteristics such as excellent water-reducing rate, high strength and compactness, good lowability, low viscosity, convenient operation, good self-leveling and environmental friendly etc. I...

Global Perphenazine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-pote...

Global N-Dimethylacetamide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

N-Dimethylacetamide (DMAC) is a colorless, high boiling, polar, hygroscopic liquid. DMAC is a good solvent for a wide range of organic and inorganic compounds and it is miscible with water, ethers, esters, ketones and aromatics compounds. It is used in the production of polyacrylonitrile and polyure...

Global Green Chelates/Natural Chelating Agents Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Chelants, also known as chelating agents, complexing, or sequestering agents, are compounds that are able to form stable complexes with metal ions. Chelants achieve this by coordinating with metal ions at a minimum of two sites, thus solubilizing and inactivating the metal ions that would othe...

Global Frac Sand Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Frac sand (or fracking sand) refers to sand and similar small materials that are used during the process of hydraulic fracturing, a method for extracting underground Natural Gas Exploration from shale gas formations. Fracking sand is a "proppant." A proppant is a material used to "prop" open the und...

Global Energy Recovery Ventilation System Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Published Date : Feb 2019

Energy recovery ventilator (ERV) is a type of mechanical equipment that features a heat exchanger combined with a ventilation system for providing controlled ventilation into a building. An energy recovery ventilator with humidity regulation incorporates a method to remove excess humidity or add hum...

 

Select License :

  • Single User : $4480
  • Corporate User : $8960

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.